SharmaALoewensteinAParachuriNKumarNKuppermannBD.Biosimilar to biosimilar anti-VEGF switching for retinal diseases. J Vitreoretin Dis. 2023;7(6):474-476.
2.
ShaheenALaiJMagranerM, et al. Clinical outcome of cystoid macular edema in silicone oil–filled eyes. J Vitreoretin Dis. 2023; 7(6):477-482.
3.
LamSSShahlaeeASalabatiMKlufasMA.Clinical outcomes of retinal arterial macroaneurysms with vitreous hemorrhage treated with observation, antivascular endothelial growth factor intravitreal injections, or pars plana vitrectomy. J Vitreoretin Dis. 2023;7(6):483-489.
4.
ShethVSSingerMMacCumberM, et al. Long-term control of retinal thickness variability and vision following the 0.19 mg fluocinolone acetonide implant. J Vitreoretin Dis. 2023;7(6): 490-497.
5.
RussellMWChalasaniMRanaN, et al. Effect of prefilled vs vial-drawn syringes on sustained increases in intraocular pressure in patients treated with aflibercept. J Vitreoretin Dis. 2023; 7(6):498-503.
6.
XuLTPriceKWRamosMSNowackiASYuanAYanJ.Outcomes of a multicenter 10-year review of postinjection endophthalmitis and associated systemic medical comorbidities. J Vitreoretin Dis. 2023;7(6):504-509.
7.
LabriolaLTVangipuramGZarnegarA, et al. Use of adjunctive corticosteroid with antivascular endothelial growth factor agents in the treatment of choroidal neovascular membrane associated with presumed ocular histoplasmosis. J Vitreoretin Dis. 2023; 7(6): 510-520.
8.
MaJPSariciKIannacconeAHadziahmetovicM.Autoimmune-related retinopathy presenting as plaquenil toxicity in patients with systemic lupus erythematosus. J Vitreoretin Dis. 2023;7(6):521-527.
9.
BinczykNMPlemelDJASeamoneMRudniskyCJTennantMTS. Decrease in anti-VEGF injections after post-injection endophthalmitis in patients with neovascular age-related macular degeneration. J Vitreoretin Dis. 2023;7(6):528-532.
10.
ValikodathNVajzovicL.Fluocinolone acetonide implant removal from the vitreous cavity. J Vitreoretin Dis. 2023;7(6): 533-535.
11.
CeloEWhelanADSeamoneCDGuptaRR.Internal plugging of a traumatic posterior perforation site using donor sclera, human amniotic membrane, and fibrin glue: a novel surgical technique. J Vitreoretin Dis. 2023;7(6):536-539.
12.
MishraKRoybalCNMahajanVB.Simultaneous bilateral open-globe repair and vitreoretinal surgery for explosive-related ocular injury. J Vitreoretin Dis. 2023;7(6):540-544.
LeeBde VosSMcCannelCA.Primary autologous stem cell transplantation for unilateral primary central nervous system lymphoma–ophthalmic variant (primary vitreoretinal lymphoma). J Vitreoretin Dis. 2023;7(6):548-551.
15.
WilsonDSPintoAMGuptaRR.Pars plana vitrectomy for vitreomacular traction resulting in persistent postoperative loculated foveal subretinal fluid. J Vitreoretin Dis. 2023;7(6): 552-556.
16.
DeanJMcTavishSFengYHoyekSPatelNA.Persistent inflammation associated with HLA-B27 after pars plana vitrectomy with scleral buckle placement. J Vitreoretin Dis. 2023;7(6):557-561.
17.
KayarianFBCohenSMCohenMLSammartinoDE.Coats plus syndrome presenting in an adult. J Vitreoretin Dis. 2023; 7(6):562-564.
